Using Machine Learning to Predict Survival in Endometrial Carcinosarcoma
Author Information
Author(s): Bove Samantha, Arezzo Francesca, Cormio Gennaro, Silvestris Erica, Cafforio Alessia, Comes Maria Colomba, Fanizzi Annarita, Accogli Giuseppe, Cazzato Gerardo, De Nunzio Giorgio, Maiorano Brigida, Naglieri Emanuele, Lupo Andrea, Vitale Elsa, Loizzi Vera, Massafra Raffaella
Primary Institution: I.R.C.C.S. Istituto Tumori “Giovanni Paolo II”, Bari, Italy
Hypothesis
Can machine learning effectively predict recurrence-free survival in endometrial carcinosarcoma patients?
Conclusion
Machine learning methods can help doctors identify endometrial carcinosarcoma patients at low or high risk of recurrence in a cost-effective way.
Supporting Evidence
- 32.5% of patients experienced recurrence.
- The model achieved a C-index of 70.00%.
- Machine learning can provide non-invasive and inexpensive predictions.
- This is the first study to propose a machine learning approach for this purpose.
Takeaway
This study used computer programs to help doctors figure out which patients with a certain type of cancer are more likely to get sick again after treatment.
Methodology
The study used machine learning to analyze clinical and histopathological data from 80 patients to predict recurrence-free survival.
Potential Biases
Potential biases may arise from the retrospective nature of the study and the limited dataset.
Limitations
The study's retrospective design and small sample size may limit the robustness and generalizability of the findings.
Participant Demographics
All participants were female patients diagnosed with endometrial carcinosarcoma.
Statistical Information
Confidence Interval
95% CI, 59.38–84.74
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website